Diabetes 53:1311-1317, 2004
© 2004 by the American Diabetes Association, Inc.
Prevalence of Hepatic Steatosis After Islet Transplantation and Its Relation to Graft Function
Ravi Bhargava1,
Peter A. Senior2,
Thomas E. Ackerman1,
Edmond A. Ryan2,
Breay W. Paty2,
Jonathan R.T. Lakey2, and
A.M. James Shapiro2
1 Department of Radiology and Diagnostic Imaging, University of Alberta, Edmonton, Alberta, Canada
2 Clinical Islet Transplant Program, University of Alberta, Edmonton, Alberta, Canada
Islet allotransplantation can provide insulin independence in selected individuals with type 1 diabetes. The long-term effects of these transplants on the liver are unknown. Recently, two cases of periportal steatosis after islet transplantation have been described. In this study, we performed ultrasound and magnetic resonance imaging (MRI) in 30 C-peptidepositive islet transplant recipients to detect steatosis and to explore the association of the radiological findings with clinical and metabolic factors. Steatosis was observed on MRI in six (20%) subjects. Histological findings of hepatic steatosis concurred with the imaging findings. Steatosis completely resolved in one subject whose graft failed. More subjects with steatosis required supplementary exogenous insulin than not (67 vs. 21%; P < 0.05). The clinical features of subjects with and without steatosis were otherwise similar, although C-peptide levels were higher in insulin-independent subjects with steatosis (0.98 ± 0.12 vs. 0.70 ± 0.18 nmol/l; P = 0.05), despite similar blood glucose levels. Serum triglycerides and the use of exogenous insulin were associated with increased odds of steatosis in a logistic regression model ( 2 [degrees freedom] = 13.6 [2]); P = 0.001). MRI-detected steatosis is a common finding; the steatosis appears to be due to a paracrine action of insulin secreted from intrahepatic islets. Hepatic steatosis may be associated with insulin resistance or graft dysfunction.
Address correspondence and reprint requests to Ravi Bhargava, MD, FRCPC, Department of Radiology and Diagnostic Imaging, 2A2.42 Walter C. Mackenzie Health Sciences Centre, University of Alberta, 8440 112 St., Edmonton, Alberta T6G 2B7, Canada. E-mail: rbhargav{at}cha.ab.ca

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
Y. Lee, M. Ravazzola, B.-H. Park, Y. K. Bashmakov, L. Orci, and R. H. Unger
Metabolic Mechanisms of Failure of Intraportally Transplanted Pancreatic {beta}-Cells in Rats: Role of Lipotoxicity and Prevention by Leptin
Diabetes,
September 1, 2007;
56(9):
2295 - 2301.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Bertuzzi and C. Ricordi
Prediction of Clinical Outcome in Islet Allotransplantation
Diabetes Care,
February 1, 2007;
30(2):
410 - 417.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Meier, I. Hong-McAtee, R. Galasso, J. D. Veldhuis, A. Moran, B. J. Hering, and P. C. Butler
Intrahepatic transplanted islets in humans secrete insulin in a coordinate pulsatile manner directly into the liver.
Diabetes,
August 1, 2006;
55(8):
2324 - 2332.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Valdes-Gonzalez
Reply to Sykes and Cozzi: 'Xenotransplantation of porcine neonatal islets of Langerhans and Sertolli cells'
Eur. J. Endocrinol.,
June 1, 2006;
154(6):
923 - 923.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Dombrowski, C. Mathieu, and M. Evert
Hepatocellular Neoplasms Induced by Low-Number Pancreatic Islet Transplants in Autoimmune Diabetic BB/Pfd Rats
Cancer Res.,
February 1, 2006;
66(3):
1833 - 1843.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. A Valdes-Gonzalez, L. M Dorantes, G N. Garibay, E. Bracho-Blanchet, A. J Mendez, R. Davila-Perez, R. B Elliott, L. Teran, and D. J G White
Xenotransplantation of porcine neonatal islets of Langerhans and Sertoli cells: a 4-year study
Eur. J. Endocrinol.,
September 1, 2005;
153(3):
419 - 427.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. A. Ryan, B. W. Paty, P. A. Senior, D. Bigam, E. Alfadhli, N. M. Kneteman, J. R.T. Lakey, and A.M. J. Shapiro
Five-Year Follow-Up After Clinical Islet Transplantation
Diabetes,
July 1, 2005;
54(7):
2060 - 2069.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2004 by the American Diabetes Association.
|
|
| |
|